| 000 | 01826 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517071815.0 | ||
| 264 | 0 | _c20160622 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1096-0333 | ||
| 024 | 7 |
_a10.1016/j.taap.2015.12.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeng, Hui | |
| 245 | 0 | 0 |
_aSuppression of NRF2-ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cFeb 2016 |
||
| 300 |
_a1-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a3T3 Cells |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntioxidant Response Elements _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEthionamide _xtherapeutic use |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
| 650 | 0 | 4 |
_aLeukemia, Monocytic, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aU937 Cells |
| 700 | 1 | _aWang, Huihui | |
| 700 | 1 | _aXue, Peng | |
| 700 | 1 | _aHou, Yongyong | |
| 700 | 1 | _aDong, Jian | |
| 700 | 1 | _aZhou, Tong | |
| 700 | 1 | _aQu, Weidong | |
| 700 | 1 | _aPeng, Shuangqing | |
| 700 | 1 | _aLi, Jin | |
| 700 | 1 | _aCarmichael, Paul L | |
| 700 | 1 | _aNelson, Bud | |
| 700 | 1 | _aClewell, Rebecca | |
| 700 | 1 | _aZhang, Qiang | |
| 700 | 1 | _aAndersen, Melvin E | |
| 700 | 1 | _aPi, Jingbo | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 292 _gp. 1-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2015.12.008 _zAvailable from publisher's website |
| 999 |
_c25579301 _d25579301 |
||